- Home
- IDAI vs NUWE Comparison
IDAI vs NUWE Comparison
Compare IDAI & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDAI
- NUWE
- Stock Information
- Founded
- IDAI 2016
- NUWE 1999
- Country
- IDAI United States
- NUWE United States
- Employees
- IDAI N/A
- NUWE N/A
- Industry
- IDAI Computer Software: Prepackaged Software
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IDAI Technology
- NUWE Health Care
- Exchange
- IDAI Nasdaq
- NUWE Nasdaq
- Market Cap
- IDAI 4.9M
- NUWE 3.9M
- IPO Year
- IDAI N/A
- NUWE N/A
- Fundamental
- Price
- IDAI $3.16
- NUWE $6.90
- Analyst Decision
- IDAI
- NUWE Strong Buy
- Analyst Count
- IDAI 0
- NUWE 1
- Target Price
- IDAI N/A
- NUWE $714.00
- AVG Volume (30 Days)
- IDAI 67.5K
- NUWE 200.5K
- Earning Date
- IDAI 08-12-2025
- NUWE 08-12-2025
- Dividend Yield
- IDAI N/A
- NUWE N/A
- EPS Growth
- IDAI N/A
- NUWE N/A
- EPS
- IDAI N/A
- NUWE N/A
- Revenue
- IDAI $3,054,143.00
- NUWE $8,787,000.00
- Revenue This Year
- IDAI $65.46
- NUWE $6.53
- Revenue Next Year
- IDAI $12.00
- NUWE $51.63
- P/E Ratio
- IDAI N/A
- NUWE N/A
- Revenue Growth
- IDAI N/A
- NUWE N/A
- 52 Week Low
- IDAI $1.43
- NUWE $6.33
- 52 Week High
- IDAI $18.75
- NUWE $196.98
- Technical
- Relative Strength Index (RSI)
- IDAI 58.37
- NUWE 27.27
- Support Level
- IDAI $2.80
- NUWE $6.33
- Resistance Level
- IDAI $3.53
- NUWE $7.82
- Average True Range (ATR)
- IDAI 0.36
- NUWE 0.93
- MACD
- IDAI 0.04
- NUWE 0.74
- Stochastic Oscillator
- IDAI 58.33
- NUWE 11.28
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.